Michel Maillard
CHDI Foundation(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Adenosine and Purinergic Signaling, HIV Research and Treatment, Protein Structure and Dynamics, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → 8‐(3‐Chlorostyryl)caffeine (CSC) is a selective A2‐adenosine antagonist in vitro and in vivo(1993)172 cited
- → Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists(1993)149 cited
- → Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease(2013)147 cited
- → Design, Synthesis, and Crystal Structure of Hydroxyethyl Secondary Amine-Based Peptidomimetic Inhibitors of Human β-Secretase(2007)110 cited
- → Structure activity relationships for derivatives of adenosine‐5′‐triphosphate as agonists at P2 purinoceptors: Heterogeneity within P2x and P2y subtypes(1994)99 cited
- → Comparative studies on the affinities of ATP derivatives for P2X‐purinoceptors in rat urinary bladder(1994)65 cited
- → Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor(2018)45 cited
- → Design, Synthesis, and Pharmacological Evaluation of Conformationally Constrained Analogues of N,N‘-Diaryl- and N-Aryl-N-aralkylguanidines as Potent Inhibitors of Neuronal Na+ Channels(1998)44 cited
- → Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington’s Disease(2021)42 cited
- → Exploiting differences in caspase-2 and -3 S2 subsites for selectivity: Structure-based design, solid-phase synthesis and in vitro activity of novel substrate-based caspase-2 inhibitors(2011)37 cited